Reevaluating Beta-Blockers: Are They Still Beneficial for Heart Patients?
A large international study called the REBOOT trial has found that beta blockers, a common treatment for heart attack survivors with normal heart function, do not provide benefits and may increase risks for women, challenging decades of standard practice.